Diminished ovarian reserve describes a lower expected egg supply or response to stimulation. Learn how AMH, ultrasound and age inform care.

Diminished ovarian reserve (DOR) refers to a reduced quantity of remaining eggs or an expectation of fewer eggs in response to ovarian stimulation compared with others of similar clinical context. It is not the same as premature ovarian insufficiency, nor does it automatically mean that a person cannot conceive without treatment. Anti-Müllerian hormone (AMH) and antral follicle count (AFC) can help predict the number of eggs obtained during IVF, but they do not reliably predict natural conception or an individual's chance of having a baby independently of age. ZagrebMed can help arrange an individualized fertility consultation in Zagreb.

What the finding means

Ovarian reserve concerns the quantity, not directly the genetic quality, of eggs remaining in the ovaries. AMH is a blood marker and AFC is an ultrasound count of small follicles. Lower values can support planning for ovarian stimulation or fertility preservation, but the result must be interpreted with age, laboratory method and clinical history. One low AMH result does not establish infertility and should not be used by itself to discourage someone from seeking medical care or treatment.

Possible causes and associated concerns

The number of eggs naturally declines with age. Earlier ovarian surgery, ovarian endometriomas, some genetic conditions, pelvic radiation and chemotherapy may also influence reserve. Some individuals have no symptoms and maintain regular cycles. Others have already undergone infertility evaluation or experienced a lower-than-expected response to fertility medication. Symptoms such as absent periods or hot flashes require assessment for ovarian insufficiency, which is a different clinical diagnosis with its own criteria.

How it is assessed

A clinician evaluates age, reproductive history, previous ovarian surgery, fertility goals and any previous stimulation outcome. AMH and AFC may be used when clinically useful; interpretation depends on the laboratory and ultrasound setting. In an female fertility laboratory assessment, tests should be selected to answer a clinical question, not ordered as a universal fertility score. Infertility evaluation also considers ovulation, reproductive anatomy and semen factors where applicable.

What the next step may involve

Management may involve discussing timing, completing additional assessment of both partners and, when indicated, planning ovarian stimulation or assisted reproduction. AMH and AFC help anticipate response and tailor counseling, but treatment choices must include age and the complete fertility picture. Even very low AMH should not be a stand-alone reason to refuse IVF treatment. Egg freezing may be discussed for specific reproductive or medical circumstances, but reserve testing should not be marketed as a reliable screening test for future natural fertility.

Important limitations and when to seek care

Seek earlier specialist assessment if there is a known risk of reduced ovarian function, prior gonadotoxic therapy, ovarian surgery or ongoing difficulty conceiving. If periods become absent or very irregular, especially with hot flashes before age 40, assessment for premature ovarian insufficiency may be needed. Severe pelvic pain or unexpected heavy bleeding deserves independent medical evaluation. Avoid interpreting a single online AMH value as a prognosis or starting unproven treatments without advice.

Interpreting the results in context

AMH and antral follicle count have important strengths and limits. They are generally useful for estimating the ovarian response to controlled stimulation and potential egg yield, especially when planning an IVF protocol. They do not precisely measure how many good-quality eggs remain, and a low result cannot independently predict whether an untreated pregnancy will occur. Age has a particularly strong influence on egg quality and reproductive outcomes. Different laboratories may use different methods and units, so historical AMH results should be compared with care. Oral contraceptives and other clinical circumstances can affect interpretation. A clinician should explain whether the test was needed and whether a repeat or an ultrasound will meaningfully alter the plan.

Practical decisions and follow-up

The planning discussion should consider whether a pregnancy is desired now, later or after a medical treatment that may affect fertility. In someone with established infertility, ovarian reserve results may inform counseling about likely response, but other causes such as tubal disease or a male factor still require appropriate attention. In a person without infertility, reserve testing is not a reliable screening test of future natural fertility and should not be used to create pressure for elective egg freezing. It may be useful to ask what the expected stimulation response is, how a previous IVF cycle changes the estimate and which options remain reasonable if few eggs are obtained. Any plan must also consider ovarian stimulation risks, the burden of treatment and personal priorities.

Preparing for a ZagrebMed inquiry

When sending an inquiry through ZagrebMed, include your age, menstrual history, how long you have been trying to conceive, previous pregnancies, surgeries, fertility medications and past IVF stimulation results. Share AMH values with test dates and units, ultrasound reports with AFC where available and any specialist findings. A clinician can explain what these results do and do not mean, whether further tests are useful and which next steps are realistic.

Related fertility conditions

A reduced egg supply should not be confused with premature ovarian insufficiency, which involves ovarian dysfunction before age 40. Ovulation disorders concern the release of an egg and may occur even when ovarian reserve is not the main issue. Distinguishing these conditions helps avoid incorrect conclusions from a single hormone result.

Medical references

Medical references: ASRM Fertility Evaluation of Infertile Women (2026); ASRM Testing and Interpreting Measures of Ovarian Reserve (2020); ESHRE Ovarian Stimulation Guideline (2025 update); WHO Guideline for Infertility (2025).

Related patient guide

Fertility tests before IVF